0585705-A1 is referenced by 79 patents and cites 3 patents.

Bacterial meningitis infection in a mammal is treated by intravenous infusion of therapeutically effective amounts of monoclonal antibodies which bind to tumor necrosis factor alpha. Treatment can be initiated up to five hours after bacterial challenge and is preferably in combination with an antibiotic selected from cephalosporins and aminoglycosides.

Title
Use of anti-tnf to treat bacterial meningitis.
Application Number
EP19930113072 19930816
Publication Number
0585705 (A1)
Application Date
August 16, 1993
Publication Date
March 9, 1994
Inventor
Collins Michael S
US
Hector Richard F
US
Assignee
Miles
US
IPC
A61K 39/395
C07K 16/18
A61K 39/395
C07K 16/24
A61K 39/395
View Original Source Download PDF